Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs GSK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN GSK PHARMA LUPIN/
GSK PHARMA
 
P/E (TTM) x 40.7 62.2 65.5% View Chart
P/BV x 6.0 18.9 31.7% View Chart
Dividend Yield % 0.2 1.6 15.0%  

Financials

 LUPIN   GSK PHARMA
EQUITY SHARE DATA
    LUPIN
Mar-23
GSK PHARMA
Mar-23
LUPIN/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs7991,684 47.4%   
Low Rs5831,231 47.4%   
Sales per share (Unadj.) Rs365.8191.9 190.6%  
Earnings per share (Unadj.) Rs9.835.9 27.4%  
Cash flow per share (Unadj.) Rs29.239.8 73.4%  
Dividends per share (Unadj.) Rs4.0032.00 12.5%  
Avg Dividend yield %0.62.2 26.4%  
Book value per share (Unadj.) Rs270.7102.9 263.1%  
Shares outstanding (eoy) m454.98169.41 268.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.97.6 24.9%   
Avg P/E ratio x70.240.6 172.9%  
P/CF ratio (eoy) x23.736.7 64.6%  
Price / Book Value ratio x2.614.2 18.0%  
Dividend payout %40.789.2 45.6%   
Avg Mkt Cap Rs m314,381246,858 127.4%   
No. of employees `000NANA-   
Total wages/salary Rs m30,8725,950 518.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m166,41732,517 511.8%  
Other income Rs m1,5091,007 149.9%   
Total revenues Rs m167,92633,524 500.9%   
Gross profit Rs m17,2068,033 214.2%  
Depreciation Rs m8,807658 1,339.1%   
Interest Rs m2,74318 15,138.0%   
Profit before tax Rs m7,1658,364 85.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,6882,288 117.5%   
Profit after tax Rs m4,4776,076 73.7%  
Gross profit margin %10.324.7 41.9%  
Effective tax rate %37.527.4 137.2%   
Net profit margin %2.718.7 14.4%  
BALANCE SHEET DATA
Current assets Rs m124,51324,943 499.2%   
Current liabilities Rs m92,65413,264 698.6%   
Net working cap to sales %19.135.9 53.3%  
Current ratio x1.31.9 71.5%  
Inventory Days Days2697 27.0%  
Debtors Days Days98216 45.5%  
Net fixed assets Rs m103,4906,988 1,481.0%   
Share capital Rs m9101,694 53.7%   
"Free" reserves Rs m122,24615,735 776.9%   
Net worth Rs m123,15617,430 706.6%   
Long term debt Rs m2750-   
Total assets Rs m228,00331,930 714.1%  
Interest coverage x3.6462.6 0.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.71.0 71.7%   
Return on assets %3.219.1 16.6%  
Return on equity %3.634.9 10.4%  
Return on capital %8.048.1 16.7%  
Exports to sales %00-   
Imports to sales %048.1 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA15,630 0.0%   
Fx inflow Rs m48,0571,622 2,963.4%   
Fx outflow Rs m21,75215,630 139.2%   
Net fx Rs m26,306-14,008 -187.8%   
CASH FLOW
From Operations Rs m18,9724,842 391.8%  
From Investments Rs m-12,8688,079 -159.3%  
From Financial Activity Rs m-3,373-15,433 21.9%  
Net Cashflow Rs m2,732-2,512 -108.7%  

Share Holding

Indian Promoters % 46.8 0.0 -  
Foreign collaborators % 0.3 75.0 0.4%  
Indian inst/Mut Fund % 45.8 11.6 395.9%  
FIIs % 16.1 2.9 549.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 53.0 25.0 211.8%  
Shareholders   281,542 114,663 245.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Lupin vs GSK Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Lupin vs GSK Pharma Share Price Performance

Period Lupin GSK Pharma S&P BSE HEALTHCARE
1-Day 1.23% 3.26% 1.18%
1-Month 0.15% -9.77% -0.75%
1-Year 151.14% 52.63% 61.82%
3-Year CAGR 17.13% 10.89% 18.16%
5-Year CAGR 17.42% 8.44% 19.79%

* Compound Annual Growth Rate

Here are more details on the Lupin share price and the GSK Pharma share price.

Moving on to shareholding structures...

The promoters of Lupin hold a 47.0% stake in the company. In case of GSK Pharma the stake stands at 75.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Lupin and the shareholding pattern of GSK Pharma.

Finally, a word on dividends...

In the most recent financial year, Lupin paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 40.7%.

GSK Pharma paid Rs 32.0, and its dividend payout ratio stood at 89.2%.

You may visit here to review the dividend history of Lupin, and the dividend history of GSK Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.